Current and historical gross, operating and net profit margins for AstraZeneca (AZN) over the last 10 years. The current net profit margin for AstraZeneca (AZN) as of March 31, 2018 is 12.61%.
||Large Cap Pharmaceutical
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.